Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Net Cash Flow (2016 - 2025)

STRATA Skin Sciences' Net Cash Flow history spans 14 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Net Cash Flow fell 29.7% year-over-year to $1.1 million; the TTM value through Sep 2025 reached -$1.3 million, down 1813.04%, while the annual FY2024 figure was $477000.0, 63.95% down from the prior year.
  • Net Cash Flow for Q3 2025 was $1.1 million at STRATA Skin Sciences, up from -$1.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $6.2 million in Q2 2023 and bottomed at -$4.0 million in Q3 2021.
  • The 5-year median for Net Cash Flow is -$749000.0 (2025), against an average of -$580842.1.
  • The largest annual shift saw Net Cash Flow plummeted 29450.0% in 2021 before it soared 800.0% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at -$461000.0 in 2021, then tumbled by 338.18% to -$2.0 million in 2022, then soared by 82.82% to -$347000.0 in 2023, then soared by 157.35% to $199000.0 in 2024, then skyrocketed by 457.79% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Net Cash Flow are $1.1 million (Q3 2025), -$1.9 million (Q2 2025), and -$749000.0 (Q1 2025).